Let's look at their price charts and technical indicators, and draw some conclusions.
Meanwhile, the latest economic data suggest the likelihood of a Fed rate cut at the next FOMC meeting.
With years of growth ahead for the company, and with the stock trading well off of its highs, now might be the time to take a look at Five Below.
Shares of the food giant may not have made a bottom, but it will be interesting to see how the stock behaves from here.
The proposed, $63 billion transaction is the latest deal in an industry where it can be cheaper to buy the science of another company than develop products.
Let's look closer at the charts and indicators of ABBV.
Plus, a look at Ulta Beauty and a possible options play in the retailer.
Let's check out the charts of TTWO this morning.
A bit of context to simmer on following the big deal between Caesars and Eldorado.
AbbVie is dropping on Allergan deal announcement, momentum is weak outside certain pockets.